Status:
NOT_YET_RECRUITING
Wearable ECG for AF Screening and Stroke Risk Assessment
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Collaborating Sponsors:
Beijing Pinggu District Hospital
Conditions:
Atrial Fibrillation
Stroke
Eligibility:
All Genders
40+ years
Brief Summary
This study aims to evaluate the application of wearable ECG garments in atrial fibrillation (AF) screening and stroke risk assessment. Using a prospective, multicenter, observational design, the study...
Detailed Description
This study is a prospective, multicenter, observational study designed to evaluate the application of wearable ECG garments in atrial fibrillation (AF) screening and stroke risk assessment. The study ...
Eligibility Criteria
Inclusion
- Age ≥ 40 years.
- High-risk stroke population identified by the "8+2" risk score in stroke screening.
- Ability to operate the device independently or with assistance from family members.
- Willingness to participate in the study and provide signed informed consent.
Exclusion
- Patients with severe diseases that limit device wear (e.g., advanced malignant tumors, severe infections, Class IV heart failure) or those receiving hospice care.
- Patients unable to operate the device or understand the study procedures due to cognitive impairment, mental illness, or language communication barriers.
- Patients who may experience severe discomfort or allergic reactions from wearing the device.
- Patients already using implanted cardiac monitoring devices.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
243 Patients enrolled
Trial Details
Trial ID
NCT06907264
Start Date
April 1 2025
End Date
December 31 2027
Last Update
April 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China, 102218
2
Pinggu District Hospital
Beijing, China, 101200